NCT02921256 2025-12-04Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal CancerNational Cancer Institute (NCI)Phase 2 Completed363 enrolled 16 charts
NCT02586610 2017-01-20Trial of Chemoradiation and Pembrolizumab in Patients With Rectal CancerHoosier Cancer Research NetworkPhase 2 Withdrawn